Its applications include: Neuropeptide signaling research Sleep mechanism modeling studies Stress physiology experimental frameworks Receptor interaction mapping Peptide stability and degradation research Procurement and Supply Chain Information DSIP research peptide is supplied through controlled laboratory-grade manufacturing and distribution channels
Its not classified as a controlled substance, but selling it as a health product violates Canadian law
Looking ahead The year 2025 is set to be noteworthy for new drug approvals, with many innovative medicines in development
Supports tissue regeneration*
DSIP does not have comparable long-term safety evidence, and the FDA has raised concerns about insufficient safety data and quality-control issues involving compounded DSIP products
CalPERS, for example, moved certain Medicare HMO and PPO plans from OptumRx to CVS Caremark effective January 1, 2026 under a new multi-year contract [2]